All Medicare Advantage Plans, Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations

Similar documents
1/6/2017. Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting. Agenda. 150 Days and Counting

Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting

MEDICARE PLAN PAYMENT GROUP

Director, Office of Hearings and Inquiries. Michael Crochunis Acting Director, Medicare Enrollment & Appeals Group

CMS Releases Proposed Rule on Medicare Advantage and Medicare Prescription Drug Plan MLR Requirements. Jacinta L. Alves

Agency Information Collection Activities: Proposed Collection; Comment Request

2017 Medicare Part D Low-Income Subsidy (LIS) Income and Resource Standards

FORM TO REQUEST DOCUMENTATION FROM AN EMPLOYER-SPONSORED HEALTH PLAN OR AN INSURER CONCERNING TREATMENT LIMITATIONS

Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2014 Benefit Year

CMS Part D UPDATES. Kim Brandt Director, Program Integrity Centers for Medicare & Medicaid Services

Transition Guidance for Non-Special Needs Enrollees in MA Special Needs Plans Under the Disproportionate Share Policy

TO: Medicare Advantage Organizations, Prescription Drug Plans, and Section 1876 Cost Plans

Understanding the Bidding Process

MEDICARE PLAN PAYMENT GROUP

Part D Performance Audits - Formulary Administration

Medicare Program; Request for Information Regarding the Physician Self-Referral Law. AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

Medicare Advantage & Prescription Drug Plan Sponsors and Certifying Actuaries. Richard F. Coyle, Jr., Acting Director, Parts C & D Actuarial Group

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for October 2008

Overview of October 24, 2013 Final Rule on Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards

WORKING WITH PRIVATE SECTOR PARTNERS TO MAXIMIZE MEDICARE SAVINGS PROGRAM AND PART D ENROLLMENT

Modifiers GA, GX, GY, and GZ

RE: Medicare Coverage Gap Discount Program Appeals Guidance

Re: Medicare Prescription Drug Benefit Manual Draft Chapter 5

Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities

GASB 45 and Medicare Part D: Understanding Your Liability and Potential Cash Subsidy

National Health Policy Forum April 28, 2005 Sally Burner CMS

SUBJECT: Contract Year 2019 Medicare Advantage Bid Review and Operations Guidance

COALITION FOR WHOLE HEALTH

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services

Medicare Parts C & D General Compliance Training

Re: Medicare Prescription Drug Benefit Manual Draft Chapter 6

Don t t Scuttle the Ship: Navigating the Regulatory Ocean in Pursuit of Part D Marketing Compliance

Medicare Advantage Value-Based Insurance Design Model Test. Responses to Stakeholder Inquiries. Last updated: November 10, 2015

MEDICARE PART D PRESCRIPTION DRUG BENEFIT

The State of Medicare Advantage 2017

TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 7 - SOCIAL SECURITY SUBCHAPTER XVIII - HEALTH INSURANCE FOR AGED AND DISABLED

CBI PAP LEGAL UPDATE MEDICARE & MEDICAID A REVIEW OF COMPLIANCE WITH GOVERNMENT PROGRAMS. September 26, Sarah difrancesca Partner Cooley LLP

RE: [CMS-4180-P] Modernizing Part D and Medicare Advantage To Lower Drug Prices and Reduce Out-of-Pocket Expenses

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for February 2008

MA/PDP Enrollment Guidance - Draft Update Comment Form Comments due 5:00 p.m. EDT July 2, 2010 Please all comments to

CMS Unveils 12-Step Reconciliation Process For Retiree Drug Subsidy (RDS)

Medicare Authorization to Disclose Personal Health Information

Center for Clinical Standards and Quality/Survey & Certification Group. Revision of Civil Money Penalty (CMP) Policies and CMP Analytic Tool

Kathryn A. Coleman, Director Medicare Drug and Health Plan Contract Administration Group

Medicare Health Plans

Medicare Plan Payment Group. Date: August 8, All Part D Plan Sponsors, including PACE Organizations

SHO # ACA # 22

MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C

ABN Changes for 2013

Eligibility and Enrollment in the Medicare Prescription Drug Program

Please print out the form below and mail your completed form to: Health Net Enrollment Services PO Box Van Nuys, CA

Via Electronic Submission ( January 16, 2018

Memorial Hermann Advantage (HMO)

January 16, Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Annual Notice of Changes for 2018

ADVANCE BENEFICIARY NOTICE OF NONCOVERAGE

Re: Prior Authorization under Medicare Advantage and the Patients over Paperwork initiative

Key Elements of Health Care Reform for Employers

HEALTH CARE FRAUD. EXPERT ANALYSIS HHS OIG Adopts New Anti-Kickback Safe Harbor and Civil Monetary Penalty Exceptions

KYHEALTH CHOICES A LOOK AT THE ISSUES: MEDICAID WAIVER PROPOSAL SUBMITTED PREPARED FOR: THE FOUNDATION FOR A HEALTHY KENTUCKY

No change from proposed rule. healthcare providers and suppliers of services (e.g.,

Subject: Plan Finder Observations During Fall Open Enrollment: October 15 December 7, 2013 Date: May 16, 2014

H e a l t h C a r e Compliance Adviser

Session 108 L, Medicare Advantage MLR: Year Two. Moderator/Presenter: Scott O Neil Jones, FSA, MAAA

Linking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance

Program of All-Inclusive Care for the Elderly (PACE) Organizations

Choosing Between Traditional Medicare and Medicare Advantage

Crackdown on Medicare Part C and Part D Marketing in 2008: Will Past be Prologue? By Daniel F. Murphy, Balch & Bingham LLP, Birmingham, AL

Medicare Transition POLICY AND PROCEDURES

Agenda. Strategic Considerations in Resolving Voluntary Government Disclosures

2/24/2017. Agenda. Determine Potential Liability. Strategic Considerations in Resolving Voluntary Government Disclosures. Relevant legal authorities:

Serevent Diskus Bridges to Access

Medicare Advantage and Other Medicare Plans 1

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

Compliance Program. Health First Health Plans Medicare Parts C & D Training

Overview of the March 29, 2016 Final Rule on the Application of Mental Health Parity Requirements to Coverage Offered by Medicaid Managed Care

Center for Medicaid, CHIP, and Survey & Certification SMDL# PPACA# 2. April 22, Re: Medicaid Prescription Drug Rebates

Medicaid Program; Disproportionate Share Hospital Payments Uninsured Definition

Released: November 16, Comments Due: January 16, 2018

Special Enrollment Periods for Medicare Advantage Plans and Medicare Part D Drug Plans 1

AMERICAN BAR ASSOCIATION. Technical Session Between the Centers for Medicare and Medicaid Services and the Joint Committee on Employee Benefits

Developed by the Centers for Medicare & Medicaid Services Issued: February, 2013

CENTERS FOR MEDICARE & MEDICAID SERVICES

Updated Guidance effective May 15, 2006 OMB DISCLOSURE OF CREDITABLE COVERAGE TO MEDICARE PART D ELIGIBLE INDIVIDUALS GUIDANCE

Short Enrollment Request Form

Agent Medicare Sales ATRIO Health Plans Oversight

Medicare Advantage (MA) Benefit Design and Beneficiary Choice

Table of Contents. Table of Contents Medicare Marketing Guidelines (MMG) Questions & Responses November 2, 2012

PEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed

Center for Medicaid and State Operations. March 22, 2007 SMDL # Dear State Medicaid Director:

Public-Private Partnerships in Medicaid Long-Term Care

Hospital Incentive Payments to Physicians for Quality and Cost Savings

REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM

Annual Compliance Deadlines for Health Plans

CMS Proposed Rulemaking For The Medicare Advantage And Medicare Prescription Drug Programs

National Policy Library Document

Medicare Advantage star ratings: Expectations for new organizations

Welcome. Medicare 101 Educational Seminar

Memorial Hermann Advantage (PPO)

American Bar Association. Technical Session Between the Centers for Medicare and Medicaid Services and the Joint Committee on Employee Benefits

Transcription:

DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C1-22-06 Baltimore, Maryland 21244-1850 MEDICARE PARTS C AND D OVERSIGHT AND ENFORCEMENT GROUP Date: To: From: Subject: March 15, 2019 All Medicare Advantage Plans, Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations John A. Scott, Acting Director Medicare Parts C and D Oversight and Enforcement Group Release of the Revised Civil Money Calculation Methodology for Comment I. Introduction The Centers for Medicare & Medicaid Services (CMS) is proposing to update the Civil Money (CMP) calculation methodology for the 2019 contract year (CY) and considering our methodology for later years. As indicated in the final CMP calculation methodology released on December 15, 2016, CMS will publish any proposed changes to the methodology prior to their utilization and provide an opportunity for comment. The CMP calculation methodology is composed of two parts: 1) how we apply or assess CMPs and 2) how we apply a formula to increase the CMPs from year to year. CMS is soliciting comments on the proposed changes to the 2019 CMP calculation methodology discussed in section III. The proposed changes to the methodology would be implemented beginning with penalties imposed as a result of enforcement referrals received in CY 2019. In section IV, CMS solicits comments on a potential formula for adjusting CMPs amounts in 2019 and beyond including the formula itself, the frequency of the adjustments, the vehicle for announcing the adjustments, and the vehicle for memorializing the calculation methodology. We have provided one example for determining the adjustment from year to year and welcome comments on it. We also welcome suggestions for alternative approaches. II. Background The CMP methodology is used by CMS to calculate penalties issued to Medicare Advantage Organizations, Part D sponsors, and other Medicare managed care organizations when CMS discovers systemic issues that may lead to beneficiary harm. Although CMS has been issuing CMPs in these programs for over ten years, the methodology used to calculate the CMPs was not made public until December 2016. CMS published a proposed draft of the methodology, solicited and evaluated public comments, and subsequently published a final methodology based Page 1 of 5

on the comments received. CMPs are calculated by applying a standard penalty amount to each deficiency. The standard penalty amount is calculated on either a per enrollee or per determination basis. CMS applies the per enrollee methodology when accurate enrollee data is available. CMS applies the per determination methodology when accurate enrollee data is either not provided by a sponsor or unknown, or when regulations require CMS to do so. Per enrollee penalties are calculated by multiplying the penalty amount by the number of affected enrollees. Per determination penalties are calculated by multiplying the penalty amount by the number of affected contracts. CMS may also increase the standard penalty amount when specific aggravating factors exist. CMS applies CMP limits to ensure an organization s CMP amount is not excessive compared to its number of enrollees. III. Clarifications and Proposed Changes Included in the 2019 CMP Calculation Methodology CMS is including the following clarification and proposed changes to the CMP calculation methodology for CY 2019: Clarifying how CMS calculates per determination standard penalties for Programs of All- Inclusive Care for the Elderly (PACE) organizations Proposal to add an aggravating factor for enrollees who never received their Part C services or Part D medications due to violations of CMS program requirements Proposal to modify the language for two aggravating factors Proposal to remove the common condition aggravating factor Clarifying how CMS Calculates Per Determination Standard Penalties for PACE Organizations The statute and regulation allow CMS to issue per determination CMPs to a Medicare PACE organization when CMS determines the PACE organization substantially failed to provide participants medically necessary items and PACE services that adversely affected (or had the substantial likelihood of adversely affecting) participants. Under this authority, CMS has been applying up to the maximum penalty permitted under regulation, as adjusted annually for inflation, per violation, per contract for PACE organizations. 1 Our December 2016 methodology did not explicitly describe how CMS calculates per determination penalties for PACE organizations. CMS is therefore clarifying in the methodology that per determination CMPs for PACE organizations are calculated consistent with our statutory and regulatory authority. Proposed Changes to Per Enrollee Aggravating Factors CMS proposes adding an aggravating factor when there was an inappropriate denial of a Part C medical service or a Part D medication and the enrollee never received the care or medication. Enrollees who never receive their services or medications are at a much greater risk for adverse harm compared to enrollees whose access was delayed. 1 CMS issued one per determination CMP to a PACE organization in 2017. Page 2 of 5

CMS proposes to modify the language for two aggravating factors. First, CMS proposes to modify the language for the aggravating factor related to the delay or denial of prescription drugs for acute conditions by changing 24 hours to one day. Second, CMS proposes to remove the Evidence of Coverage (EOC) from the second aggravating factor related to untimely and inaccurate plan benefit information because the Annual Notice of Change (ANOC) and the EOC have become two independent (stand-alone) documents with different delivery requirements and flexibilities. CMS also proposes to remove the aggravating factor for violations that are among the top conditions in the Medicare Part C and Part D Program Audit and Enforcement Report. IV. Adjustments to CMP Amounts CMS is proposing to adjust the amounts for CMPs using the approach described below. However, we request comments and suggestions on that approach and welcome ideas for alternatives. CMS also welcomes comments and suggestions on how to memorialize the methodology for adjusting CMP amounts and the frequency for adjusting CMP amounts. CMS is considering establishing the methodology for adjusting CMP amounts in regulation, and by regulation, granting CMS the discretion to adjust CMP amounts no more often than every three years. CMS currently conducts program audits in three-year cycles. Thus, under this potential approach, organizations that are audited within a cycle would be subject to the same penalty level. If CMS lengthened an audit cycle to four or more years, we could continue applying the penalty amounts for the duration of the cycle and would update the amounts before a new cycle begins. If CMS chooses to no longer conduct audits in cycles, CMS would adjust CMP amounts no more often than every three years. Background The Federal Civil Penalties Inflation Adjustment Act Improvement Act of 2015 (Sec. 701 of Pub. L. 114-74) requires agencies to adjust the maximum CMP amounts for inflation annually. The Office of Management and Budget (OMB) releases the multiplier agencies must use to calculate penalty increases for the following year. 2 CMS, however, has the discretion to set CMP amounts below the maximum amount required by law. Prior to 2014, CMS based the overall amount of a CMP on a number of factors, including the severity of the deficiency, the extent to which the deficiency was systemic, and the enrollment of the sponsor. CMS implemented a pilot in 2014 that standardized the calculation of CMPs by establishing penalty amounts for specific types of violations and applying the amounts consistently among MA organizations and Part D plan sponsors. CMS adopted this framework in the 2017 CMP Methodology and increased the penalty amounts to encourage better compliance with CMS rules and account for inflation. Per Enrollee Amounts in 2017 and 2018 Standard : $200 2 See OMB Memorandum M-19-04 for the 2019 inflation adjustment multiplier. Available at: https://www.whitehouse.gov/wp-content/uploads/2017/11/m_19_04.pdf Page 3 of 5

Aggravating Factors: $100 Untimely/Inaccurate Beneficiary Communications Standard : $25 Untimely/Inaccurate Beneficiary Communications Aggravating Factor: $15 Proposed Per Enrollee Amounts for 2019-2021 Standard : $212 Aggravating Factors: $106 Untimely/Inaccurate Beneficiary Communications Standard : $27 Untimely/Inaccurate Beneficiary Communications Aggravating Factor: $16 Proposed Approach for Increasing the Amounts CMS could increase the standard penalty amount by multiplying the penalty amount by the costof-living multiplier published annually by OMB. 3 CMS would track the accrual of the standard penalty amounts each year, but would update the standard penalty amount no more often than every three years. When the standard penalty amount is updated, CMS will increase the penalty by the amounts that would have applied if CMS had multiplied the standard penalty amount by the cost-of-living multiplier each year. The following table shows how CMS used this approach to calculate the proposed CMP amounts for 2019. The same methodology would be applied for subsequent 3-year audit periods, beginning in 2022. Table 1: Proposed CMP Standard adjustment for 2019 Adjustment Year OMB Multiplier Starting Standard (Accrual) Standard After Adjustment (Accrual) Applied Standard Each Year 2017* 1.01636 $200 $203 $200 2018* 1.02041 $203 $207 $200 2019 1.02522 $207 $212 $212 *These amount are not the actual amounts for 2017-2018. See the background section above for the amounts that applied in 2017-2018. This table illustrates how CMS would apply the OMB multiplier to calculate the 2019 standard penalty of $212. Table 2: Proposed CMP Aggravating Factors and Untimely or Inaccurate Material adjustments 3 Per OMB Memoranda M-19-04, Implementation of Inflation Adjustments for 2019, Pursuant to the Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015, published December 14, 2018, the costof-living adjustment multiplier for 2019 is 1.02522. Page 4 of 5

Adjustment Year Applied Standard Aggravating Factor (AF) Untimely or Inaccurate Materials Untimely or Inaccurate Materials AF Applied Other Penalties & AFs Each Year 2017 $200 $100 $25 $15 $100 / $25 / $15 2019 $212 $106 $27 $16 $106 / $27 / $16 V. Submission of Comments The proposed methodology is attached to this notice, and can also be downloaded from the Downloads section of the following CMS webpage: https://www.cms.gov/medicare/compliance-and-audits/part-c-and-part-d-compliance-and- Audits/PartCandPartDEnforcementActions-.html If you wish to comment on the revised CMP methodology, please submit your comments to the following email address: part_c_part_d_audit@cms.hhs.gov. Please include 2019 CMP Methodology Comments in the subject line. Comments must be received by 11:59PM ET on April 15, 2019. CMS hopes to publish a final methodology within 30 days of the comment deadline. Page 5 of 5